New England Journal of Medicine

Print ISSN
0028-4793
Electronic ISSN
1533-4406
Impact factor
53.486
Publisher
Proquest
URL
http://www.nejm.org/loi/nejm
Usage rank
17
Article count
74857
Free count
10006
Free percentage
0.133668
PDFs via platforms
Gale, Highwire, Ovid, CSA, and Proquest

  1. Controversies in the Treatment of Early-Stage Hodgkin's Lymphoma

    New England Journal of Medicine 372(17):1667 (2015) PMID 25901431

    Hodgkin’s lymphoma affects about 8000 patients a year in the United States, and with available therapies, about 7000 of them will be cured. Although room for improvement still exists, recent clinical research has focused on determining how little therapy can be given to maintain the cu...
  2. Use of Cell-free DNA to Screen for Down's Syndrome

    New England Journal of Medicine 372(17):1666 (2015) PMID 25830324

    Standard prenatal screening for trisomy 21 (Down's syndrome) is based on a combination of maternal age, maternal serum biomarkers, and fetal ultrasonographic findings. Such screening can identify 70 to 90% of fetuses with trisomy 21 with a false positive rate of 2 to 5%.1 Screening tha...
  3. Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines
    Author(s) unavailable

    New England Journal of Medicine 372(17):1677 (2015) PMID 25901443

    Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines Special Article, N Engl J Med 2015;372:447-455. In Table 3 (page 452), the unit given below the “Change in Cardiovascular Costs, as Compared with Status Quo” column head should have been “millions of $,” rather tha...
  4. Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

    New England Journal of Medicine 372(17):1672 (2015) PMID 25901437

    To the Editor: The results of the Suppression of Ovarian Function Trial (SOFT) by Francis et al. (Jan. 29 issue)1 are presented as practice changing. However, we are concerned about the emphasis given to the receipt of adjuvant chemotherapy — which was considered as a proxy for a disea...
  5. Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

    New England Journal of Medicine 372(17):1670 (2015) PMID 25901432

    To the Editor: Vannucchi et al. (Jan. 29 issue)1 report that ruxolitinib was superior to standard therapy in patients with polycythemia vera who had an inadequate response to or had unacceptable side effects from hydroxyurea. The primary end point included hematocrit control and a redu...
  6. Factor XI Antisense Oligonucleotide for Venous Thrombosis

    New England Journal of Medicine 372(17):1671 (2015) PMID 25901434

    To the Editor: I would caution against concluding, on the basis of the study by Büller et al. (Jan. 15 issue),1 that reducing factor XI levels attenuates the risk of thrombosis without increasing the risk of bleeding. Factor XI deficiency selectively increases the risk of bleeding in t...
  7. A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
    Author(s) unavailable

    New England Journal of Medicine 372(17):1677 (2015) PMID 25901444

    A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis Original Article, N Engl J Med 2014;371:1588-1598. In Table 2 (page 1594), the values given in the Control Group column in the third row from the bottom of the table should have been 53/676 (7.8), rather than 753/67...
  8. This Week in the Journal
    Author(s) unavailable

    New England Journal of Medicine 372(17):1588 (2015)

  9. Case 3-2015: A Woman with Abdominal Pain, Dyspnea, and Diplopia

    New England Journal of Medicine 372(17):1674 (2015) PMID 25901441

    To the Editor: In the case of a 60-year-old woman with abdominal pain, dyspnea, and diplopia who received a diagnosis of botulism (Jan. 22 issue),1 one of the differential diagnoses was the Guillain–Barré syndrome. We would like to point out that variants of the Guillain–Barré syndrome...
  10. Treatment of Ebola

    New England Journal of Medicine 372(17):1673 (2015) PMID 25901439

    To the Editor: We were struck by the similarity of transient vascular leak in Ebola virus disease (EVD), as reported by Lyon et al. (Dec. 18 issue),1 with that which occurs in dengue. When severe dengue was first described, uncorrected hypovolemia often led to shock, hemorrhage, and de...